Evotec AG Stock
There is nearly no change for the Evotec AG stock today. Compared to yesterday it only changed by €0.030.
With 25 Buy predictions and 1 Sell predictions Evotec AG is one of the favorites of our community.
With a target price of €40.00 there is a slightly positive potential of 15.908% for Evotec AG compared to the current price of €34.51.
Our community identified positive and negative aspects for Evotec AG stock for the coming years. 4 users see the criterium "Revenue growth" as a plus for the Evotec AG stock. On the other hand our users think that "Balance Sheet Risk" could be a problem in the future.
Pros and Cons of Evotec AG in the next few years
Pros
4
Revenue growth >5% per year expected
3
Could be very worthwhile Investment >20% year
3
Medium risks for its business
Cons
1
Risky balance sheet
1
Few uniques
Performance of Evotec AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Evotec AG | 0.090% | -1.794% | -7.758% | 53.586% | 14.399% | 98.560% | 728.249% |
| MorphoSys AG | -0.300% | -6.986% | -27.098% | -56.671% | -50.192% | -56.851% | 22.330% |
| Halozyme Therapeutics Inc. | 2.030% | -4.418% | -10.966% | 50.779% | 0.317% | - | - |
| Invitae Corp | 0.680% | 1.924% | -15.190% | -3.852% | -34.016% | - | - |
Comments
Other discussions about Evotec AG Stock
Trading Evotec AG
Trading Evotec AG
